chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Hypoxia, PO2 decreased, SARS-CoV-2 test positive, Sinus rhythm
Clinical narrative: Presented to the ED with complaints generalized weakness prompting a call to EMS who found patient diaphoretic per report.  Patient endorses dry cough but denies any fevers, chills, chest pain, palpitations, lightheadedness or dizziness.  Upon arrival to the ED patient's initial vitals revealed hypoxia in the 80s and up to 90% on room air.  ABG revealed hypoxemia with PO2 70.6.  COVID-19 positive.  Patient was tachypneic max 22.  Mildly decreased sodium 134 and elevated serum creatinine 1.53 (baseline III to 1.5, patient with history CKD stage 3).  Decreased magnesium 1.5.   - Troponin elevated 117 with BNP 261.  EKG reveals sinus rhythm with no ST segment changes acutely. - Chest x-ra  Presented to the ED with complaints generalized weakness prompting a call to EMS who found patient diaphoretic per report.  Patient endorses dry cough but denies any fevers, chills, chest pain, palpitations, lightheadedness or dizziness.  Upon arrival to the ED patient's initial vitals revealed hypoxia in the 80s and up to 90% on room air.  ABG revealed hypoxemia with PO2 70.6.  COVID-19 positive.  Patient was tachypneic max 22.  Mildly decreased sodium 134 and elevated serum creatinine 1.53 (baseline III to 1.5, patient with history CKD stage 3).  Decreased magnesium 1.5.   - Troponin elevated 117 with BNP 261.  EKG reveals sinus rhythm with no ST segment changes acutely. - Chest x-ray pending at time of admission.   Patient is fully vaccinated against COVID-19 with Moderna x2.  Exposed to daughter who has COVID-19. Tested positive on 01/17/2022
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tachypnoea, Troponin increased
Clinical narrative: Presented to the ED with complaints generalized weakness prompting a call to EMS who found patient diaphoretic per report.  Patient endorses dry cough but denies any fevers, chills, chest pain, palpitations, lightheadedness or dizziness.  Upon arrival to the ED patient's initial vitals revealed hypoxia in the 80s and up to 90% on room air.  ABG revealed hypoxemia with PO2 70.6.  COVID-19 positive.  Patient was tachypneic max 22.  Mildly decreased sodium 134 and elevated serum creatinine 1.53 (baseline III to 1.5, patient with history CKD stage 3).  Decreased magnesium 1.5.   - Troponin elevated 117 with BNP 261.  EKG reveals sinus rhythm with no ST segment changes acutely. - Chest x-ra  Presented to the ED with complaints generalized weakness prompting a call to EMS who found patient diaphoretic per report.  Patient endorses dry cough but denies any fevers, chills, chest pain, palpitations, lightheadedness or dizziness.  Upon arrival to the ED patient's initial vitals revealed hypoxia in the 80s and up to 90% on room air.  ABG revealed hypoxemia with PO2 70.6.  COVID-19 positive.  Patient was tachypneic max 22.  Mildly decreased sodium 134 and elevated serum creatinine 1.53 (baseline III to 1.5, patient with history CKD stage 3).  Decreased magnesium 1.5.   - Troponin elevated 117 with BNP 261.  EKG reveals sinus rhythm with no ST segment changes acutely. - Chest x-ray pending at time of admission.   Patient is fully vaccinated against COVID-19 with Moderna x2.  Exposed to daughter who has COVID-19. Tested positive on 01/17/2022
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abnormal behaviour, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Hypotension
Clinical narrative: Presented to the ED from group home due to change in mentation and behavior, nausea, vomiting.  Per EMS patient was hypoxic and hypotensive with blood pressure 88/54.  Patient unable to contribute to history.  Patient with reported history of recent COVID-19 infection.   - ED workup significant for oxygen saturation 88% on room air, RR 21, WBC 2.67, positive COVID-19 and bilateral pneumonia on chest x-ray - Patient with hypotensive episodes 86/64 prior to sepsis fluid administration. Tested positive on 01/15/2022   Presented to the ED from group home due to change in mentation and behavior, nausea, vomiting.  Per EMS patient was hypoxic and hypotensive with blood pressure 88/54.  Patient unable to contribute to history.  Patient with reported history of recent COVID-19 infection.   - ED workup significant for oxygen saturation 88% on room air, RR 21, WBC 2.67, positive COVID-19 and bilateral pneumonia on chest x-ray - Patient with hypotensive episodes 86/64 prior to sepsis fluid administration.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, Mental status changes, Nausea, Pneumonia, SARS-CoV-2 test positive
Clinical narrative: Presented to the ED from group home due to change in mentation and behavior, nausea, vomiting.  Per EMS patient was hypoxic and hypotensive with blood pressure 88/54.  Patient unable to contribute to history.  Patient with reported history of recent COVID-19 infection.   - ED workup significant for oxygen saturation 88% on room air, RR 21, WBC 2.67, positive COVID-19 and bilateral pneumonia on chest x-ray - Patient with hypotensive episodes 86/64 prior to sepsis fluid administration. Tested positive on 01/15/2022   Presented to the ED from group home due to change in mentation and behavior, nausea, vomiting.  Per EMS patient was hypoxic and hypotensive with blood pressure 88/54.  Patient unable to contribute to history.  Patient with reported history of recent COVID-19 infection.   - ED workup significant for oxygen saturation 88% on room air, RR 21, WBC 2.67, positive COVID-19 and bilateral pneumonia on chest x-ray - Patient with hypotensive episodes 86/64 prior to sepsis fluid administration.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sepsis, Vomiting, White blood cell count decreased
Clinical narrative: Presented to the ED from group home due to change in mentation and behavior, nausea, vomiting.  Per EMS patient was hypoxic and hypotensive with blood pressure 88/54.  Patient unable to contribute to history.  Patient with reported history of recent COVID-19 infection.   - ED workup significant for oxygen saturation 88% on room air, RR 21, WBC 2.67, positive COVID-19 and bilateral pneumonia on chest x-ray - Patient with hypotensive episodes 86/64 prior to sepsis fluid administration. Tested positive on 01/15/2022   Presented to the ED from group home due to change in mentation and behavior, nausea, vomiting.  Per EMS patient was hypoxic and hypotensive with blood pressure 88/54.  Patient unable to contribute to history.  Patient with reported history of recent COVID-19 infection.   - ED workup significant for oxygen saturation 88% on room air, RR 21, WBC 2.67, positive COVID-19 and bilateral pneumonia on chest x-ray - Patient with hypotensive episodes 86/64 prior to sepsis fluid administration.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anxiety, COVID-19, Chest pain, Death of relative, Depressed mood
Clinical narrative: He came to the hospital with a chief complaint of left-sided chest pain.  Patient also reported some dizziness associated with that.  Pain is less in the left lateral chest wall.  Patient reports that recently his wife passed away so he is feeling very down and anxious.  He reports that his chest pain may have something to do with that.  He denies any fevers, chills, cough, shortness of breath, palpitations, abdominal pain, nausea, vomiting, burning or painful urination, diarrhea.  Patient however denies any severe depressive symptoms or suicidal ideations.  Tested positive on 01/16/2022
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, SARS-CoV-2 test positive
Clinical narrative: He came to the hospital with a chief complaint of left-sided chest pain.  Patient also reported some dizziness associated with that.  Pain is less in the left lateral chest wall.  Patient reports that recently his wife passed away so he is feeling very down and anxious.  He reports that his chest pain may have something to do with that.  He denies any fevers, chills, cough, shortness of breath, palpitations, abdominal pain, nausea, vomiting, burning or painful urination, diarrhea.  Patient however denies any severe depressive symptoms or suicidal ideations.  Tested positive on 01/16/2022
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Anosmia, Blood magnesium decreased, COVID-19, Cough
Clinical narrative: Patient is fully vaccinated. COVID + on 12/1/2021.  ED visit on 12/1/2021.The patient complains of 5 days of cough, fever, anosmia, abdominal pain, diarrhea. She has shortness of breath.  Positive for fatigue, diarrhea, nausea and vomiting.  BP 112/61  | Pulse 94  | Temp 99.7 °F (37.6 °C)  | Resp 18  | Ht 157.5 cm (5' 2")  | Wt 104 kg (230 lb)  | SpO2 94%  | BMI 42.07 kg/m² CXR with infiltrates.  Mg low, replaced.  Referred for monoclonal antibodies.  Return to ED if worse.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Nausea, Pyrexia
Clinical narrative: Patient is fully vaccinated. COVID + on 12/1/2021.  ED visit on 12/1/2021.The patient complains of 5 days of cough, fever, anosmia, abdominal pain, diarrhea. She has shortness of breath.  Positive for fatigue, diarrhea, nausea and vomiting.  BP 112/61  | Pulse 94  | Temp 99.7 °F (37.6 °C)  | Resp 18  | Ht 157.5 cm (5' 2")  | Wt 104 kg (230 lb)  | SpO2 94%  | BMI 42.07 kg/m² CXR with infiltrates.  Mg low, replaced.  Referred for monoclonal antibodies.  Return to ED if worse.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Patient is fully vaccinated. COVID + on 12/1/2021.  ED visit on 12/1/2021.The patient complains of 5 days of cough, fever, anosmia, abdominal pain, diarrhea. She has shortness of breath.  Positive for fatigue, diarrhea, nausea and vomiting.  BP 112/61  | Pulse 94  | Temp 99.7 °F (37.6 °C)  | Resp 18  | Ht 157.5 cm (5' 2")  | Wt 104 kg (230 lb)  | SpO2 94%  | BMI 42.07 kg/m² CXR with infiltrates.  Mg low, replaced.  Referred for monoclonal antibodies.  Return to ED if worse.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Skin burning sensation, Tremor, Urticaria
Clinical narrative: within seconds horrible headache and dizziness.  within 10 minutes sever burning over skin on feet, legs, chest and scalp that developed into hives..  Developed shakes over body for near 12 hours.  took Benadryl and Motrin to combat head ache and hives.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Raised red areas noted to arms, back, chest, back of the knees, with severe itch. Booster given on Friday 1/14/22 @FACILITY. Red areas continue to be itchy on 1/20/22
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Meniere's disease, Vertigo
Clinical narrative: Vertigo - diagnosed with Meniere's
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nephrolithiasis, Ultrasound scan
Clinical narrative: 4 kidney stones in 3 weeks.  Never had kidney stones before,  have not had any since.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID BREAKTHROUGH CASE
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Fatigue, Inappropriate schedule of product administration
Clinical narrative: Hospitalized for COVID 19 infection normal chest xray. Extreme fatigue and weakness.   BOOSTER Pfizer,Inc LOT FC3184 R arm on 10/5/2021.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Broke out over chest area
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered after expiration deadline for use.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Adnexa uteri pain, Anxiety, Arthralgia, Chills, Confusional state
Clinical narrative: 104 fever  Shakes  Chills  Ovary pain  Join pain Body aches  Sweating  Headache  Anxiety  Dizziness  Confusion Light headed
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hyperhidrosis, Pain, Pyrexia
Clinical narrative: 104 fever  Shakes  Chills  Ovary pain  Join pain Body aches  Sweating  Headache  Anxiety  Dizziness  Confusion Light headed
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: 104 fever  Shakes  Chills  Ovary pain  Join pain Body aches  Sweating  Headache  Anxiety  Dizziness  Confusion Light headed
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Lethargy, SARS-CoV-2 test positive
Clinical narrative: Patient was vaccinated with Pfizer on 3/18/21 and 4/8/21. Patient has been admitted to hospital for COVID since 1/19/22 after presenting with lethargy and weakness
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, COVID-19, COVID-19 pneumonia, Computerised tomogram thorax abnormal
Clinical narrative: Patient is fully vaccinated.  COVID + on 12/1/2021.  Hospitalized from 12/1/2021 to 12/13/2021.  Patient expired. Admitted with COVID 19,  Pneumonia due to COVID, acute hypoxic respiratory failure.  88-year-old gentleman with a significant known history for peripheral arterial disease/chronic bronchitis/coronary artery disease status post intervention/stent placement, presented due to complaint of shortness ofbreath which has been progressively getting worse.  The patient was saturating 95% on 15 L non-rebreather, up from 69% on home 4 L nasal cannula. CT PE protocol :No evidence of acute pulmonary embolism; Worsening in aeration of the right lung; Stable left lung infiltrates.  Treatment:  remdesivir, decadron.  Afib with RVR, Metoprolol given. Hyperkalemia. D dimer 3,521.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Fibrin D dimer, Hyperkalaemia, Lung infiltration
Clinical narrative: Patient is fully vaccinated.  COVID + on 12/1/2021.  Hospitalized from 12/1/2021 to 12/13/2021.  Patient expired. Admitted with COVID 19,  Pneumonia due to COVID, acute hypoxic respiratory failure.  88-year-old gentleman with a significant known history for peripheral arterial disease/chronic bronchitis/coronary artery disease status post intervention/stent placement, presented due to complaint of shortness ofbreath which has been progressively getting worse.  The patient was saturating 95% on 15 L non-rebreather, up from 69% on home 4 L nasal cannula. CT PE protocol :No evidence of acute pulmonary embolism; Worsening in aeration of the right lung; Stable left lung infiltrates.  Treatment:  remdesivir, decadron.  Afib with RVR, Metoprolol given. Hyperkalemia. D dimer 3,521.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient is fully vaccinated.  COVID + on 12/1/2021.  Hospitalized from 12/1/2021 to 12/13/2021.  Patient expired. Admitted with COVID 19,  Pneumonia due to COVID, acute hypoxic respiratory failure.  88-year-old gentleman with a significant known history for peripheral arterial disease/chronic bronchitis/coronary artery disease status post intervention/stent placement, presented due to complaint of shortness ofbreath which has been progressively getting worse.  The patient was saturating 95% on 15 L non-rebreather, up from 69% on home 4 L nasal cannula. CT PE protocol :No evidence of acute pulmonary embolism; Worsening in aeration of the right lung; Stable left lung infiltrates.  Treatment:  remdesivir, decadron.  Afib with RVR, Metoprolol given. Hyperkalemia. D dimer 3,521.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaemia, Asthenia, Blood iron normal, Blood sodium decreased, COVID-19
Clinical narrative: Hospitalized 01/07/2022; COVID-19 positive 01/07/2022; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD Admission Date: 1/7/2022 Discharge Date: 01/17/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Fall, initial encounter  COVID-19  UTI (urinary tract infection)    HOSPITAL COURSE: Patient is an 89-year-old male with a past medical history of prostate cancer with chronic indwelling Foley on Xtandi and hypertension who presented status post mechanical fall.  Patient had a fever at home the day prior to admission.  He was generally weak for about a month per his report.  On the day of admission he was walking with his walker to the commode and he stumbled and fell into the fireplace.  He struck his head.  He has bruising around his right eye and right temple.  He did not lose consciousness.  His indwelling Foley had been changed 2 days prior to admission.  He denied upper respiratory infection symptoms at that time.  In the emergency department, he was found to be COVID positive and had a positive urinalysis for infection.  Head CT and C-spine CT were negative for acute fracture or bleed.  Chest x-ray was negative for infiltrate.  Labs showed a sodium 132, hemoglobin 10 and platelet count 92000. Was initially placed on IV Rocephin.  He did not meet criteria for remdesivir or Decadron due to lack of hypoxia.  He did agree to monoclonal antibodies and tolerated that infusion.  Urine culture grew Pseudomonas.  He was changed to cefepime at that time.  At discharge he was changed to Cipro.     After admission he did admit to diarrhea, which was felt to be a COVID symptom.  He did have enteric pathogens that were positive for Shiga toxin.  He did not have signs of  HUS.  He was treated supportively.  He received fluids.  Anemia thrombocytopenia workup was negative for hemolysis, primary bone marrow abnormality or obvious iron deficiency.  He seemed consistent with acute illness as the source of his thrombocytopenia. This improved during his stay.   The patient continued to be weak.  PT/OT initially recommended subacute rehab but patient improved and they recommended HHC.  The patient was recommended to follow up with his primary care physician.  He was discharged home in stable condition
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray normal, Computerised tomogram head normal, Computerised tomogram normal, Contusion, Culture urine positive
Clinical narrative: Hospitalized 01/07/2022; COVID-19 positive 01/07/2022; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD Admission Date: 1/7/2022 Discharge Date: 01/17/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Fall, initial encounter  COVID-19  UTI (urinary tract infection)    HOSPITAL COURSE: Patient is an 89-year-old male with a past medical history of prostate cancer with chronic indwelling Foley on Xtandi and hypertension who presented status post mechanical fall.  Patient had a fever at home the day prior to admission.  He was generally weak for about a month per his report.  On the day of admission he was walking with his walker to the commode and he stumbled and fell into the fireplace.  He struck his head.  He has bruising around his right eye and right temple.  He did not lose consciousness.  His indwelling Foley had been changed 2 days prior to admission.  He denied upper respiratory infection symptoms at that time.  In the emergency department, he was found to be COVID positive and had a positive urinalysis for infection.  Head CT and C-spine CT were negative for acute fracture or bleed.  Chest x-ray was negative for infiltrate.  Labs showed a sodium 132, hemoglobin 10 and platelet count 92000. Was initially placed on IV Rocephin.  He did not meet criteria for remdesivir or Decadron due to lack of hypoxia.  He did agree to monoclonal antibodies and tolerated that infusion.  Urine culture grew Pseudomonas.  He was changed to cefepime at that time.  At discharge he was changed to Cipro.     After admission he did admit to diarrhea, which was felt to be a COVID symptom.  He did have enteric pathogens that were positive for Shiga toxin.  He did not have signs of  HUS.  He was treated supportively.  He received fluids.  Anemia thrombocytopenia workup was negative for hemolysis, primary bone marrow abnormality or obvious iron deficiency.  He seemed consistent with acute illness as the source of his thrombocytopenia. This improved during his stay.   The patient continued to be weak.  PT/OT initially recommended subacute rehab but patient improved and they recommended HHC.  The patient was recommended to follow up with his primary care physician.  He was discharged home in stable condition
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Diarrhoea, Escherichia test positive, Fall, Haemoglobin decreased, Head injury
Clinical narrative: Hospitalized 01/07/2022; COVID-19 positive 01/07/2022; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD Admission Date: 1/7/2022 Discharge Date: 01/17/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Fall, initial encounter  COVID-19  UTI (urinary tract infection)    HOSPITAL COURSE: Patient is an 89-year-old male with a past medical history of prostate cancer with chronic indwelling Foley on Xtandi and hypertension who presented status post mechanical fall.  Patient had a fever at home the day prior to admission.  He was generally weak for about a month per his report.  On the day of admission he was walking with his walker to the commode and he stumbled and fell into the fireplace.  He struck his head.  He has bruising around his right eye and right temple.  He did not lose consciousness.  His indwelling Foley had been changed 2 days prior to admission.  He denied upper respiratory infection symptoms at that time.  In the emergency department, he was found to be COVID positive and had a positive urinalysis for infection.  Head CT and C-spine CT were negative for acute fracture or bleed.  Chest x-ray was negative for infiltrate.  Labs showed a sodium 132, hemoglobin 10 and platelet count 92000. Was initially placed on IV Rocephin.  He did not meet criteria for remdesivir or Decadron due to lack of hypoxia.  He did agree to monoclonal antibodies and tolerated that infusion.  Urine culture grew Pseudomonas.  He was changed to cefepime at that time.  At discharge he was changed to Cipro.     After admission he did admit to diarrhea, which was felt to be a COVID symptom.  He did have enteric pathogens that were positive for Shiga toxin.  He did not have signs of  HUS.  He was treated supportively.  He received fluids.  Anemia thrombocytopenia workup was negative for hemolysis, primary bone marrow abnormality or obvious iron deficiency.  He seemed consistent with acute illness as the source of his thrombocytopenia. This improved during his stay.   The patient continued to be weak.  PT/OT initially recommended subacute rehab but patient improved and they recommended HHC.  The patient was recommended to follow up with his primary care physician.  He was discharged home in stable condition
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test normal, Platelet count decreased, Pseudomonas test positive, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Hospitalized 01/07/2022; COVID-19 positive 01/07/2022; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD Admission Date: 1/7/2022 Discharge Date: 01/17/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Fall, initial encounter  COVID-19  UTI (urinary tract infection)    HOSPITAL COURSE: Patient is an 89-year-old male with a past medical history of prostate cancer with chronic indwelling Foley on Xtandi and hypertension who presented status post mechanical fall.  Patient had a fever at home the day prior to admission.  He was generally weak for about a month per his report.  On the day of admission he was walking with his walker to the commode and he stumbled and fell into the fireplace.  He struck his head.  He has bruising around his right eye and right temple.  He did not lose consciousness.  His indwelling Foley had been changed 2 days prior to admission.  He denied upper respiratory infection symptoms at that time.  In the emergency department, he was found to be COVID positive and had a positive urinalysis for infection.  Head CT and C-spine CT were negative for acute fracture or bleed.  Chest x-ray was negative for infiltrate.  Labs showed a sodium 132, hemoglobin 10 and platelet count 92000. Was initially placed on IV Rocephin.  He did not meet criteria for remdesivir or Decadron due to lack of hypoxia.  He did agree to monoclonal antibodies and tolerated that infusion.  Urine culture grew Pseudomonas.  He was changed to cefepime at that time.  At discharge he was changed to Cipro.     After admission he did admit to diarrhea, which was felt to be a COVID symptom.  He did have enteric pathogens that were positive for Shiga toxin.  He did not have signs of  HUS.  He was treated supportively.  He received fluids.  Anemia thrombocytopenia workup was negative for hemolysis, primary bone marrow abnormality or obvious iron deficiency.  He seemed consistent with acute illness as the source of his thrombocytopenia. This improved during his stay.   The patient continued to be weak.  PT/OT initially recommended subacute rehab but patient improved and they recommended HHC.  The patient was recommended to follow up with his primary care physician.  He was discharged home in stable condition
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thrombocytopenia, Urinary tract infection, Urine analysis abnormal, Walking aid user
Clinical narrative: Hospitalized 01/07/2022; COVID-19 positive 01/07/2022; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD Admission Date: 1/7/2022 Discharge Date: 01/17/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Fall, initial encounter  COVID-19  UTI (urinary tract infection)    HOSPITAL COURSE: Patient is an 89-year-old male with a past medical history of prostate cancer with chronic indwelling Foley on Xtandi and hypertension who presented status post mechanical fall.  Patient had a fever at home the day prior to admission.  He was generally weak for about a month per his report.  On the day of admission he was walking with his walker to the commode and he stumbled and fell into the fireplace.  He struck his head.  He has bruising around his right eye and right temple.  He did not lose consciousness.  His indwelling Foley had been changed 2 days prior to admission.  He denied upper respiratory infection symptoms at that time.  In the emergency department, he was found to be COVID positive and had a positive urinalysis for infection.  Head CT and C-spine CT were negative for acute fracture or bleed.  Chest x-ray was negative for infiltrate.  Labs showed a sodium 132, hemoglobin 10 and platelet count 92000. Was initially placed on IV Rocephin.  He did not meet criteria for remdesivir or Decadron due to lack of hypoxia.  He did agree to monoclonal antibodies and tolerated that infusion.  Urine culture grew Pseudomonas.  He was changed to cefepime at that time.  At discharge he was changed to Cipro.     After admission he did admit to diarrhea, which was felt to be a COVID symptom.  He did have enteric pathogens that were positive for Shiga toxin.  He did not have signs of  HUS.  He was treated supportively.  He received fluids.  Anemia thrombocytopenia workup was negative for hemolysis, primary bone marrow abnormality or obvious iron deficiency.  He seemed consistent with acute illness as the source of his thrombocytopenia. This improved during his stay.   The patient continued to be weak.  PT/OT initially recommended subacute rehab but patient improved and they recommended HHC.  The patient was recommended to follow up with his primary care physician.  He was discharged home in stable condition
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fracture, Inflammation, Influenza like illness, Laboratory test
Clinical narrative: Had the shot on June 16th. On June 20th when I went to get out of bed my back was hurting and continued to get worse as the day progressed. By Wednesday I was in such severe pain that I went to Urgent care and they said I had severe inflammation in the middle of my back. I was sent to a chiropractor, and a massage therapist before finally having an MRI done on my back which showed I had a fracture in the center of my back. I believe that this came about after being sent to the chiropractor and one of the instruments that was used on my back caused that. I have been put on steroids and pain meds for the inflammation and still have pain in my back. I have gotten my booster shot and had mild flu symptoms and the pain got severe again. Some days it is extremely bad and some it just hurts. I believe that this has been brought about from the shot.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging abnormal, Pain
Clinical narrative: Had the shot on June 16th. On June 20th when I went to get out of bed my back was hurting and continued to get worse as the day progressed. By Wednesday I was in such severe pain that I went to Urgent care and they said I had severe inflammation in the middle of my back. I was sent to a chiropractor, and a massage therapist before finally having an MRI done on my back which showed I had a fracture in the center of my back. I believe that this came about after being sent to the chiropractor and one of the instruments that was used on my back caused that. I have been put on steroids and pain meds for the inflammation and still have pain in my back. I have gotten my booster shot and had mild flu symptoms and the pain got severe again. Some days it is extremely bad and some it just hurts. I believe that this has been brought about from the shot.
Sex: U
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: pt admitted with Covid vaccination
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: RESEARCH VISIT not related to COVID 19.
Sex: U
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: admit to hospital with covid vaccination
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Antibiotic (Doxycycline) prescribed for infection after vaccination.  Red spot at injection site, 3-4 inches, warm, not raised.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Moderna administered to underaged patient (17 years)
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, Hypoxia, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Patient fully vaccinated with Moderna 1/21/21 and 2/27/21. Patient admitted 1/19/22 with COVID19 after having symptoms of worsening shortness of breath and hypoxia over 4-5 days. Patient is still admitted
Sex: U
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: positive covid with vaccination
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Headache, Nausea, Pyrexia
Clinical narrative: Severe fever and chills began 4 hours after vaccine administration and lasted for 24 hours. Nausea, vomiting, and abdominal distress began 12 hours after administration. Vomiting ceased after 8 hours while nausea and abdominal distress are still present 48 hours after administration. Severe headache has been present since the fever and chills began and is resistant to any medication. Sleep is greatly disturbed and headache is still as bad as it was initially.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Vomiting
Clinical narrative: Severe fever and chills began 4 hours after vaccine administration and lasted for 24 hours. Nausea, vomiting, and abdominal distress began 12 hours after administration. Vomiting ceased after 8 hours while nausea and abdominal distress are still present 48 hours after administration. Severe headache has been present since the fever and chills began and is resistant to any medication. Sleep is greatly disturbed and headache is still as bad as it was initially.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered after expiration deadline for use.
Sex: U
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive covid test with vaccination of covid
Sex: U
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: admit to hospital with positive covid test.  Was vaccinated for covid
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Hypoxia, Immunoglobulin therapy, Inappropriate schedule of product administration
Clinical narrative: Hospitalized with Hypoxic Covid pneumonia had monoclonal antibodies on 1/6/2022. IVIG on 1/13.    Sars-COV-2 Moderna vaccine booster given 8/25/2021 NO FURTHER INFORMATION ON VACCINE
Sex: U
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: admit to the hospital with covid positive, was vaccinated
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Death, Dyspnoea
Clinical narrative: Admitted to Hospital  on 1/3/22 with c/o of fever, SOB, myalgia, headache, n/v, SOB, difficulty breathing x4 days.  Admitted and diagnosed with COVID 19, pneumonia, acute respiratory failure.  Reported to hospital that he had received Janseen COVID vaccine on 7/27/21, but information was not in state immunization system.  Expired at hospital on 1/14/22 from COVID 19 infection.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Myalgia, Nausea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Admitted to Hospital  on 1/3/22 with c/o of fever, SOB, myalgia, headache, n/v, SOB, difficulty breathing x4 days.  Admitted and diagnosed with COVID 19, pneumonia, acute respiratory failure.  Reported to hospital that he had received Janseen COVID vaccine on 7/27/21, but information was not in state immunization system.  Expired at hospital on 1/14/22 from COVID 19 infection.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Admitted to Hospital  on 1/3/22 with c/o of fever, SOB, myalgia, headache, n/v, SOB, difficulty breathing x4 days.  Admitted and diagnosed with COVID 19, pneumonia, acute respiratory failure.  Reported to hospital that he had received Janseen COVID vaccine on 7/27/21, but information was not in state immunization system.  Expired at hospital on 1/14/22 from COVID 19 infection.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Disease complication
Clinical narrative: Admitted to Hospital  on 1/3/22 with c/o of fever, SOB, myalgia, headache, n/v, SOB, difficulty breathing x4 days.  Admitted and diagnosed with COVID 19, pneumonia, acute respiratory failure.  Reported to hospital that he had received Janseen COVID vaccine on 7/27/21, but information was not in state immunization system.  Expired at hospital on 1/14/22 from COVID 19 infection.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered after expired use limit date.
Sex: U
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: pt positive for covid, did receive covid vaccine
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Rash, Vertigo
Clinical narrative: Rash on neck even as of today 2 weeks later Dizziness/vertigo
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Erythema, Herpes zoster, Pain, Paraesthesia, Scar
Clinical narrative: Shingles. Started is tingling sensation in torso. Then became red and painful, then erupted into fluid filled boils with extreme pain. Video visit with doctor gave me the diagnosis. I though it could be poison ivy. They wanted to prescribe an antiviral medication but we were in rural at the time and I couldn't get to a Pharmacy or any other pharmacy in time. Once I returned home I got gabapentin which offered little help. Increased dosing did a little more. Scarring is still present to this day.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered after expired use limit date.
Sex: U
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: admit to the hospital with covid.  Did receive full covid vaccination
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Decreased appetite, Dyspnoea
Clinical narrative: Patient is fully vaccinated. COVID + on 12/14/2021.  ED visit on 12/14/2021.  Vaccinated patient whose wife is currently admitted with Covid presents with a one week h/o loss of apetite, nause and vomiting. Denies any fevers or chills, no chest pain or dyspnea. Positive for cough. BP 92/52  | Pulse 73  | Temp 99.6 °F (37.6 °C) (Oral)  | Resp 18  | Ht 167.6 cm (5' 6")  | Wt 98.9 kg (218 lb)  | SpO2 94%  | BMI 35.19 kg/m² Patient states she feels better after meds and fluids.  He is asking to be discharged.  Patient's oxygen saturation remains in mid 90's at rest.  Per the patient's request discussed his case with the patient's daughter, who expressed some concerns about his oxygenation when active. We ambulated the patient and monitored his pulse ox and it never dropped below 92% and when he returned to his room his pulse ox ws 97%. He never experience any dyspnea or chest pain while ambulating. CXR: Right basilar airspace change consistent with infiltrate. Information were sent to Dr. office for them to contact him in regards to Monoclonal Antibody Treatment. It was emphasized both to the patient and his daughter that if his pulse ox drops below 90% for him to return immediately to the ER.  Patient back to the ED on 12/16/2021 for SOB.  The patient states he woke up to go to the bathroom tonight and he felt weak. Approximately 1 week of sx, vaccinated, tested positive for covid 2 days ago. He is nauseous. He has not vomited. He does not have diarrhea.  He has been taking tylenol every 4 hours, ibuprofen intermittently. Has not yet received mAB therapy but has been referred for it. BP 131/63  | Pulse 82  | Temp (!) 103 °F (39.4 °C) (Oral)  | Resp 16  | Ht 167.6 cm (5' 6")  | Wt 98.9 kg (218 lb)  | SpO2 93%  | BMI 35.19 kg/m² CXR with patchy infiltrates, consistent with covid. Will DC home; encouraged to f/u with monoclonal ab therapy as previously referred Continue conservative care at home.  Return to the ED if worse.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Patient is fully vaccinated. COVID + on 12/14/2021.  ED visit on 12/14/2021.  Vaccinated patient whose wife is currently admitted with Covid presents with a one week h/o loss of apetite, nause and vomiting. Denies any fevers or chills, no chest pain or dyspnea. Positive for cough. BP 92/52  | Pulse 73  | Temp 99.6 °F (37.6 °C) (Oral)  | Resp 18  | Ht 167.6 cm (5' 6")  | Wt 98.9 kg (218 lb)  | SpO2 94%  | BMI 35.19 kg/m² Patient states she feels better after meds and fluids.  He is asking to be discharged.  Patient's oxygen saturation remains in mid 90's at rest.  Per the patient's request discussed his case with the patient's daughter, who expressed some concerns about his oxygenation when active. We ambulated the patient and monitored his pulse ox and it never dropped below 92% and when he returned to his room his pulse ox ws 97%. He never experience any dyspnea or chest pain while ambulating. CXR: Right basilar airspace change consistent with infiltrate. Information were sent to Dr. office for them to contact him in regards to Monoclonal Antibody Treatment. It was emphasized both to the patient and his daughter that if his pulse ox drops below 90% for him to return immediately to the ER.  Patient back to the ED on 12/16/2021 for SOB.  The patient states he woke up to go to the bathroom tonight and he felt weak. Approximately 1 week of sx, vaccinated, tested positive for covid 2 days ago. He is nauseous. He has not vomited. He does not have diarrhea.  He has been taking tylenol every 4 hours, ibuprofen intermittently. Has not yet received mAB therapy but has been referred for it. BP 131/63  | Pulse 82  | Temp (!) 103 °F (39.4 °C) (Oral)  | Resp 16  | Ht 167.6 cm (5' 6")  | Wt 98.9 kg (218 lb)  | SpO2 93%  | BMI 35.19 kg/m² CXR with patchy infiltrates, consistent with covid. Will DC home; encouraged to f/u with monoclonal ab therapy as previously referred Continue conservative care at home.  Return to the ED if worse.
Sex: U
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: positive covid test.  was vaccinated with covid vaccine
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Alanine aminotransferase decreased, Arthralgia, Aspartate aminotransferase decreased, Blood magnesium normal
Clinical narrative: Received COVID19 vaccine booster dose on 9 December, 12 days prior to onset of symptoms. Since 21 December he has complained of recurrent episodes of generalized hives which last for less than 24 hours and resolve without post-inflammatory changes. His symptoms led him to present to the ER on 21 December where he was initially treated with Benadryl, Famotidine, and Decadron before being released. On 23 December he again presented to the ER for hives and swelling around his eyes and his throat causing difficulty breathing which led to him being treated with epinephrine, Benadryl, famotidine, and solumedrol; he was admitted overnight for observation. Review of medical record reveals that he was complaining of sore throat, hoarse voice, abdominal pain, chest tightness, and joint pain (no swelling noted on examination). By report EMS team found patient to be hypotensive when they initially arrived to his home prior to transport to ER. Since that time he has continued to experience daily hives with occasional swelling of his soles. Since his hospitalization he denies interval laryngeal, GI, neurologic, and cardiovascular symptoms with his hives. Episodes not associated with cold, foods, heat/sweating, exercise, medications, NSAID use, latex exposure, alcohol, IV contrast, illness, or insect bites/stings. More recently he notes hives at sites where he is scraped, scratched, or exposed to pressure.. He reports episodes of fever (Tmax 100F) during this time but denies night sweats, unexplained weight loss, and generalized red/painful/swollen joints outside of symptoms which led to his hospitalization. He has used oral antihistamines with limited benefit but feels Prednisone helped his symptoms.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Blood phosphorus normal, C-reactive protein normal, Chest discomfort, Dysphonia, Dyspnoea
Clinical narrative: Received COVID19 vaccine booster dose on 9 December, 12 days prior to onset of symptoms. Since 21 December he has complained of recurrent episodes of generalized hives which last for less than 24 hours and resolve without post-inflammatory changes. His symptoms led him to present to the ER on 21 December where he was initially treated with Benadryl, Famotidine, and Decadron before being released. On 23 December he again presented to the ER for hives and swelling around his eyes and his throat causing difficulty breathing which led to him being treated with epinephrine, Benadryl, famotidine, and solumedrol; he was admitted overnight for observation. Review of medical record reveals that he was complaining of sore throat, hoarse voice, abdominal pain, chest tightness, and joint pain (no swelling noted on examination). By report EMS team found patient to be hypotensive when they initially arrived to his home prior to transport to ER. Since that time he has continued to experience daily hives with occasional swelling of his soles. Since his hospitalization he denies interval laryngeal, GI, neurologic, and cardiovascular symptoms with his hives. Episodes not associated with cold, foods, heat/sweating, exercise, medications, NSAID use, latex exposure, alcohol, IV contrast, illness, or insect bites/stings. More recently he notes hives at sites where he is scraped, scratched, or exposed to pressure.. He reports episodes of fever (Tmax 100F) during this time but denies night sweats, unexplained weight loss, and generalized red/painful/swollen joints outside of symptoms which led to his hospitalization. He has used oral antihistamines with limited benefit but feels Prednisone helped his symptoms.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count abnormal, Hypotension, Leukocytosis, Lymphopenia, Metabolic function test abnormal
Clinical narrative: Received COVID19 vaccine booster dose on 9 December, 12 days prior to onset of symptoms. Since 21 December he has complained of recurrent episodes of generalized hives which last for less than 24 hours and resolve without post-inflammatory changes. His symptoms led him to present to the ER on 21 December where he was initially treated with Benadryl, Famotidine, and Decadron before being released. On 23 December he again presented to the ER for hives and swelling around his eyes and his throat causing difficulty breathing which led to him being treated with epinephrine, Benadryl, famotidine, and solumedrol; he was admitted overnight for observation. Review of medical record reveals that he was complaining of sore throat, hoarse voice, abdominal pain, chest tightness, and joint pain (no swelling noted on examination). By report EMS team found patient to be hypotensive when they initially arrived to his home prior to transport to ER. Since that time he has continued to experience daily hives with occasional swelling of his soles. Since his hospitalization he denies interval laryngeal, GI, neurologic, and cardiovascular symptoms with his hives. Episodes not associated with cold, foods, heat/sweating, exercise, medications, NSAID use, latex exposure, alcohol, IV contrast, illness, or insect bites/stings. More recently he notes hives at sites where he is scraped, scratched, or exposed to pressure.. He reports episodes of fever (Tmax 100F) during this time but denies night sweats, unexplained weight loss, and generalized red/painful/swollen joints outside of symptoms which led to his hospitalization. He has used oral antihistamines with limited benefit but feels Prednisone helped his symptoms.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Monocytosis, Neutrophilia, Oropharyngeal pain, Periorbital swelling, Peripheral swelling
Clinical narrative: Received COVID19 vaccine booster dose on 9 December, 12 days prior to onset of symptoms. Since 21 December he has complained of recurrent episodes of generalized hives which last for less than 24 hours and resolve without post-inflammatory changes. His symptoms led him to present to the ER on 21 December where he was initially treated with Benadryl, Famotidine, and Decadron before being released. On 23 December he again presented to the ER for hives and swelling around his eyes and his throat causing difficulty breathing which led to him being treated with epinephrine, Benadryl, famotidine, and solumedrol; he was admitted overnight for observation. Review of medical record reveals that he was complaining of sore throat, hoarse voice, abdominal pain, chest tightness, and joint pain (no swelling noted on examination). By report EMS team found patient to be hypotensive when they initially arrived to his home prior to transport to ER. Since that time he has continued to experience daily hives with occasional swelling of his soles. Since his hospitalization he denies interval laryngeal, GI, neurologic, and cardiovascular symptoms with his hives. Episodes not associated with cold, foods, heat/sweating, exercise, medications, NSAID use, latex exposure, alcohol, IV contrast, illness, or insect bites/stings. More recently he notes hives at sites where he is scraped, scratched, or exposed to pressure.. He reports episodes of fever (Tmax 100F) during this time but denies night sweats, unexplained weight loss, and generalized red/painful/swollen joints outside of symptoms which led to his hospitalization. He has used oral antihistamines with limited benefit but feels Prednisone helped his symptoms.